The global ophthalmoscopes market is estimated to be valued at US$246.4 Mn or Million in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

SWOT Analysis:-

·         Strengths: Advanced LED illumination systems provide higher quality exams. Portable designs allow examinations to be conducted anywhere.

·         Weaknesses: Higher costs than traditional designs. Learning curve for newer technologies.

·         Opportunities: Growth in eye care infrastructure in developing nations. Expanding geriatric population driving demand.

·         Threats: Increased competition from low-cost alternatives. Reimbursement cuts kön reduce diagnostic testing volumes.

Key Takeaways:-

The Global Ophthalmoscopes Market Growth is expected to witness high growth, exhibiting CAGR of 4.7% over the forecast period, due to increasing investments in eye care infrastructure across developing regions.

Regional analysis: North America dominated the ophthalmoscopes market in 2023, owing to presence of major players and rapid adoption of technologically advanced devices. Asia Pacific is expected to witness fastest growth over the forecast period supported by rising eye care awareness and expanding health cover in countries like India and China.

Key players operating in the ophthalmoscopes market include Custom Ultrasonics, Inc., EndoMed Systems GmbH., Fujifilm Holdings Corporation, PENTAX Medical Company, Ambu A/S, Medline Industries, Inc., Heine USA Ltd., US Ophthalmic, Welch Allyn, Hill-Rom Holdings Inc (Hillrom), Dino-Lite Europe, HONSUN Group, Rudolf Riester GmbH, IRIDEX Corporation, Zumax Medical Co., Ltd., Oscar Boscarol S.r.l., Suzhou Kangjie Medical Inc., NIDEK Inc., and KIRCHNER & WILHELM GmbH Co. KG.

Read More - https://www.feedsfloor.com/other/open-new-avenue-ophthalmoscopes-market